Etanercept News and Research

RSS
Etanercept (Enbrel) is a drug that treats autoimmune diseases by interfering with the TNF receptor (a part of the immune system) by acting as a TNF inhibitor.
FDA extends action date for Pfizer’s tofacitinib NDA review

FDA extends action date for Pfizer’s tofacitinib NDA review

Study compares mortality rates among RA patients treated with individual TNF inhibitors

Study compares mortality rates among RA patients treated with individual TNF inhibitors

Shingles vaccine may not increase risk of varicella in people with auto-immune diseases

Shingles vaccine may not increase risk of varicella in people with auto-immune diseases

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

TB research finds body’s own response helps TB bacteria survive

TB research finds body’s own response helps TB bacteria survive

Psoriasis TNF-α therapeutic effects mediated by MSC antioxidant reduction

Psoriasis TNF-α therapeutic effects mediated by MSC antioxidant reduction

Anti-TNFs increase risk for herpes zoster infections in IRD patients

Anti-TNFs increase risk for herpes zoster infections in IRD patients

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Steroids still work better for patients with sciatica

Steroids still work better for patients with sciatica

New guidelines offer guidance on how and when to switch between RA drug classes

New guidelines offer guidance on how and when to switch between RA drug classes

NHS approves new rheumatoid arthritis drug RoActemra

NHS approves new rheumatoid arthritis drug RoActemra

Juvenile arthritis affected kids are at a high risk of cancer: Study

Juvenile arthritis affected kids are at a high risk of cancer: Study

Incident malignancy four times higher among children with JIA

Incident malignancy four times higher among children with JIA

PDUFA goal date of NDA for Protalix's taliglucerase alfa extended

PDUFA goal date of NDA for Protalix's taliglucerase alfa extended

TNF inhibitors may minimally increase risk of serious infections

TNF inhibitors may minimally increase risk of serious infections

Study evaluates JIA disease activity after treatment with etanercept

Study evaluates JIA disease activity after treatment with etanercept

Children with polyarticular JIA benefit from early and aggressive therapy

Children with polyarticular JIA benefit from early and aggressive therapy

Link between use of anti-TNF therapy and malignant melanoma in RA patients

Link between use of anti-TNF therapy and malignant melanoma in RA patients

Doctors may stop anti-TNF medications for RA patients before surgery to reduce disease flares

Doctors may stop anti-TNF medications for RA patients before surgery to reduce disease flares

Psychological stress can trigger flares of vasculitis

Psychological stress can trigger flares of vasculitis